Buy low, sell high

2 March 2018 By Robyn Mak

Zhou Hongyi led a $9 bln buyout of his U.S.-listed antivirus firm in 2016. Now its successor is trading in China at $56 bln. That far outstrips what most hedge funds or commodity traders achieve in years of arbitraging price gaps. Alas for copycats, this is not easy to follow.

This content is for Subscribers only

To access full content you must be a subscriber. Please use the following link to request a trial.


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)